Answers are grounded in this paper and cite their sources.
Alzheimer’s disease (AD) is biologically heterogeneous, and plant-derived natural products provide chemically diverse starting points for multi-target discovery. Reproducible prioritization is needed to distinguish literature-supported evidence from candidate-specific predictions not yet generated. Our objective was to develop a reproducible, evidence-informed framework for prioritizing plant-derived natural products in AD and define a transparent candidate library and prespecified screening set for subsequent computational and experimental evaluation. Completed work included selection of an AD target panel (AChE/BChE, BACE1, GSK-3β and MAO-B), synthesis of a published target-specific machine-learning (ML) benchmark, curation of a 20-compound candidate library with traceable chemical identities and literature support, and selection of a 13-compound prespecified screening set. Published performance metrics were treated solely as external benchmark evidence. Study-specific model training, prospective ML screening, molecular docking, BBB/drug-likeness and ADMET evaluation, multi-objective ranking, and experimental validation were prespecified as future work and were not performed. The framework links mechanistically justified targets, published ML benchmarks, a chemically diverse 20-compound library, and a 13-compound set for future screening. The library includes evidence-rich reference compounds and comparatively underexplored scaffolds; no candidate-specific computational ranking or selection outcome is reported. This study presents an evidence-informed, multi-target computational framework for prioritizing plant-derived natural products in Alzheimer’s disease. Its methodological contribution lies in integrating a mechanistically defined target panel, published machine-learning benchmarks, a traceable 20-compound candidate library, and a prespecified 13-compound screening set within a transparent prospective evaluation strategy. By distinguishing completed framework-development activities from future computational and experimental analyses, the study establishes a structured foundation for subsequent model validation, multi-objective prioritization, and experimental investigation.
No takes yet. Share an insight, caveat, or question.
Eman S. Allahyani (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: